Valneva | search
Click here to view Valneva news from 60+ newspapers.
Bookmark or Share- The Valneva VLA2001 COVID-19 vaccine: What you need to knowThis webpage was published on 18 August 2022. The Valneva vaccine is a purified, inactivated, and adjuvanted whole virus SARS-CoV-2 vaccine. The WHO Strategic Advisory Group of Experts on Immunization (SAGE) has issued interim policy recommendations for the use of the Valneva (VLA2001) vaccine.
- Valneva and Pfizer Report Positive Pediatric and Adolescent Phase 2 ...Saint-Herblain (France) & New York, September 7, 2023 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) and Pfizer Inc. (NYSE: PFE) announced today positive pediatric and adolescent immunogenicity and safety data for their Lyme disease vaccine candidate, VLA15, when given as a booster.
- Home - ValnevaWelcome to Valneva. We are a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs. We have leveraged our expertise and capabilities both to commercialize three vaccines, including the world’s first and only chikungunya vaccine, and to rapidly ...
- Valneva USA - Advancing vaccines for better livesfor better lives. Valneva USA Inc. is focused on the marketing and distribution of Valneva’s vaccine for Chikungunya and Japanese Encephalitis.
- Valneva Reports Positive Phase 3 Results for Inactivated, Adjuvanted ...Saint Herblain (France), October 18, 2021 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced positive topline results from the Phase 3 pivotal trial Cov-Compare of its inactivated, adjuvanted COVID-19 vaccine candidate, VLA2001.
More
